A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Solid Tumor
Related studies linked through entity extraction aliases.
S095029 as Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies Followed by an Expansion Part With Triple Combinations in Patients With Metastatic Gastric or Colorectal Cancers
- Status
- COMPLETED
- Phase
- PHASE1
A Study of PRS-344/S095012 (PD-L1x4-1BB Bispecific Antibody-Anticalin Fusion) in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs
- Status
- RECRUITING
- Phase
- PHASE2
A Phase Ia Clinical Study of QLF31907 Injection in Patients With Advanced Malignant Tumors
- Status
- RECRUITING
- Phase
- PHASE1
RAPA-201 Therapy of Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Clinical Study of Intratumoral Administration of RT-01 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Text-based Intervention to Minimize the Time Burden of Routine Cancer Care
- Status
- COMPLETED
- Phase
- NA
A Study of NDI 1150-101 in Patients With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A PET Imaging Agent to Assess the Level of Tumor Tissue-infiltrating CD8 + T Cells in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients in China
- Status
- TERMINATED
- Phase
- PHASE1
A Phase I Study of IBI325 in Patients With Advanced Solid Tumor
- Status
- COMPLETED
- Phase
- PHASE1
Study of Sacituzumab Govitecan in Patients With Solid Tumor
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
ADC Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of HER-2 Positive Advanced Solid Tumors(PRaG3.0)
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Absorption-Distribution-Metabolism-Excretion (ADME) of [14C]IMP4297 to China Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trial of WBC100 on Advanced Solid Tumor
- Status
- TERMINATED
- Phase
- PHASE1
Local Radiotherapy in Combination With Immunotherapy in Advanced Solid Tumors Patients
- Status
- UNKNOWN
- Phase
- PHASE2
A Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive Glioblastoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1